|
DNAJC21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.230000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.936000E-01 |
| Normal-vs-Stage2 |
1.225810E-01 |
| Normal-vs-Stage3 |
3.541800E-01 |
| Normal-vs-Stage4 |
1.068600E-01 |
| Stage1-vs-Stage2 |
3.641800E-01 |
| Stage1-vs-Stage3 |
9.405800E-01 |
| Stage1-vs-Stage4 |
2.565800E-02 |
| Stage2-vs-Stage3 |
4.376800E-01 |
| Stage2-vs-Stage4 |
1.250150E-02 |
| Stage3-vs-Stage4 |
3.250000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.232200E-01 |
| Normal-vs-AfricanAmerican |
2.083800E-01 |
| Normal-vs-Asian |
1.040350E-01 |
| Caucasian-vs-AfricanAmerican |
8.376200E-02 |
| Caucasian-vs-Asian |
6.802700E-03 |
| AfricanAmerican-vs-Asian |
8.861600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.093160E-01 |
| Normal-vs-Female |
7.202800E-01 |
| Male-vs-Female |
1.442000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.631000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.471600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.430200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.519200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.134200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.720200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.567400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.838400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.575400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.874400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.498400E-01 |
| Classical-VS-Follicular |
3.33969999988248E-07 |
| Classical-VS-Other |
5.402200E-01 |
| Classical-VS-Normal |
5.338600E-01 |
| Tall-VS-Follicular |
1.858180E-03 |
| Tall-VS-Other |
5.185800E-01 |
| Tall-VS-Normal |
6.373200E-01 |
| Follicular-VS-Other |
3.220400E-01 |
| Follicular-VS-Normal |
2.372400E-04 |
| Other-VS-Normal |
7.100000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.438100E-03 |
| Normal-vs-N1 |
4.474600E-01 |
| N0-vs-N1 |
1.098090E-02 |
|
|
